Australija - engleski - Department of Health (Therapeutic Goods Administration)

church and dwight australia pty ltd - zinc oxide -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

church and dwight australia pty ltd - zinc oxide -

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

wallace pharmaceuticals inc. - cromolyn sodium (unii: q2wxr1i0pk) (cromolyn - unii:y0tk0fs77w) - cromolyn sodium 20 mg in 1 ml - cromolyn sodium, usp is indicated in the management of patients with mastocytosis. use of this product has been associated with improvement in diarrhea, flushing, headaches, vomiting, urticaria, abdominal pain, nausea, and itching in some patients. cromolyn sodium, usp is contraindicated in those patients who have shown hypersensitivity to cromolyn sodium.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

wallace pharmaceuticals inc. - hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - hyoscyamine sulfate 0.125 mg - hyoscyamine sulfate tablets are effective as adjunctive therapy in the treatment of peptic ulcer. they can also be used to control gastric secretion, visceral spasm and hypermotility in spastic colitis, spastic bladder, cystitis, pylorospasm, and associated abdominal cramps. may be used in functional intestinal disorders to reduce symptoms such as those seen in mild dysenteries, diverticulitis, and acute enterocolitis. for use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and functional gastrointestinal disorders. also used as adjunctive therapy in the treatment of neurogenic bladder and neurogenic bowel disturbances (including the splenic flexure syndrome and neurogenic colon). hyoscyamine sulfate tablets are indicated along with morphine or other narcotics in symptomatic relief of biliary and renal colic; as a “drying agent” in the relief of symptoms of acute rhinitis; in the therapy of parkinsonism to reduce rigidity and tremors and to control associated sialorrhea and hyperhidrosis. may be used in the therapy of poisoning by anticholinesterase agents. glaucoma; obstructive uropathy (for example, bladder neck obstruction due to prostatic hypertrophy); obstructive disease of the gastrointestinal tract (as in achalasia, pyloroduodenal stenosis); paralytic ileus, intestinal atony of elderly or debilitated patients; unstable cardiovascular status in acute hemorrhage; severe ulcerative colitis; toxic megacolon complicating ulcerative colitis; myasthenia gravis.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

wallace pharmaceuticals inc. - hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - hyoscyamine sulfate 0.125 mg - hyoscyamine sulfate sublingual tablets are effective as adjunctive therapy in the treatment of peptic ulcer. they can also be used to control gastric secretion, visceral spasm and hypermotility in spastic colitis, spastic bladder, cystitis, pylorospasm, and associated abdominal cramps. may be used in functional intestinal disorders to reduce symptoms such as those seen in mild dysenteries, diverticulitis, and acute enterocolitis. for use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and functional gastrointestinal disorders. also used as adjunctive therapy in the treatment of neurogenic bladder and neurogenic bowel disturbances (including the splenic flexure syndrome and neurogenic colon). hyoscyamine sulfate sublingual tablets are indicated along with morphine or other narcotics in symptomatic relief of biliary and renal colic; as a “drying agent” in the relief of symptoms of acute rhinitis; in the therapy of parkinsonism to reduce rigidit

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

wallace pharmaceuticals inc. - hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - hyoscyamine sulfate 0.375 mg - hyoscyamine sulfate extended-release tablets are effective as adjunctive therapy in the treatment of peptic ulcer. they can also be used to control gastric secretion, visceral spasm and hypermotility in spastic colitis, spastic bladder, cystitis, pylorospasm, and associated abdominal cramps. may be used in functional intestinal disorders to reduce symptoms such as those seen in mild dysenteries, diverticulitis, and acute enterocolitis. for use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and functional gastrointestinal disorders. also used as adjunctive therapy in the treatment of neurogenic bladder andmneurogenic bowel disturbances (including the splenic flexure syndrome and neurogenic colon). hyoscyamine sulfate extended-release tablets are indicated along with morphine or other narcotics in symptomatic relief of biliary and renal colic; as a “drying agent” in the relief of symptoms of acute rhinitis; in the therapy of parkinsonism to re

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

wallace manufacturing chemists ltd - riboflavin; thiamine hydrochloride; pyridoxine hydrochloride; ascorbic acid; calcium pantothenate; calcium levulinate; calcium chloride dihydrate; nicotinamide - oral solution - 25microgram/1ml ; 100microgram/1ml ; 25microgram/1ml ; 1mg/1ml ; 25microgram/1ml ; 70mg/1ml ; 24mg/1ml ; 400microgram/1ml

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

wallace manufacturing chemists ltd - vitamin a; ergocalciferol; ascorbic acid; thiamine nitrate; riboflavin; pyridoxine hydrochloride; nicotinamide; calcium pantothenate; alpha tocopheryl acetate - oral capsule - 5000unit ; 500unit ; 40mg ; 2.5mg ; 2.5mg ; 1mg ; 20mg ; 5mg ; 2unit

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

wallace manufacturing chemists ltd - dexpanthenol; pyridoxine hydrochloride; nicotinamide; riboflavin sodium phosphate; thiamine hydrochloride; vitamin a; ergocalciferol; ascorbic acid; sodium ascorbate - oral drops - 4mg/1ml ; 2mg/1ml ; 25mg/1ml ; 2mg/1ml ; 4mg/1ml ; 10000unit/1ml ; 1000unit/1ml ; 38.7mg/1ml ; 68.88mg/1ml

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

wallace manufacturing chemists ltd - vitamin a; ergocalciferol; ascorbic acid; sodium ascorbate; thiamine hydrochloride; riboflavin sodium phosphate; pyridoxine hydrochloride; nicotinamide; dexpanthenol - oral solution - 1000unit/1ml ; 100unit/1ml ; 3.87mg/1ml ; 6.89mg/1ml ; 400microgram/1ml ; 200microgram/1ml ; 200microgram/1ml ; 2.5mg/1ml ; 400microgram/1ml